InspireMD (NSPR) Net Cash Flow Growth (3y) (2013 - 2025)
InspireMD (NSPR) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 33.47% |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn | -332.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -332.39% |
| Sep 30, 2025 | 184.94% |
| Jun 30, 2025 | 11.08% |
| Mar 31, 2025 | -16.18% |
| Dec 31, 2024 | 69.64% |
| Sep 30, 2024 | 23.72% |
| Jun 30, 2024 | 34.63% |
| Mar 31, 2024 | -26.16% |
| Dec 31, 2023 | -63.72% |
| Sep 30, 2023 | 40.61% |
| Jun 30, 2023 | -68.90% |
| Mar 31, 2023 | 45.46% |
| Dec 31, 2022 | 34.32% |
| Sep 30, 2022 | -45.06% |
| Jun 30, 2022 | -8.03% |
| Mar 31, 2022 | -5.52% |
| Dec 31, 2021 | 15.93% |
| Sep 30, 2021 | -99.84% |
| Jun 30, 2021 | -50.71% |
| Mar 31, 2021 | 223.68% |